Presented by U.S. Pharmacopeia (USP), the Science and Standards Symposium on Biologics and Biotechnology aims to gather biologics and biotechnology (B&B) professionals, regulators, and researchers to discuss topics related to B&B analytics and assays, including the regulatory landscape and the role of USP standards. Topics will include measurement of post-translational modifications, critical quality attributes and compendial standards for monoclonal antibodies and enzymes, and the role and importance of biological potency reference standards for biologics.
Xu-Rong Jiang will be giving an oral presentation on "Industry Perspective on MAb CQAs: Fc Effector Functionality." MedImune is a sponsor.
Added by MedImmune on September 26, 2011